– Dr. R. Dean Hautamaki Named ASA Senior Medical Advisor – Florida
– Eric Kaplan, Esq. Joins ASA Board of Directors 2021 – ASA Grant Opportunities Now Available
Earlier this year, when ASA decided to expand to an area where it could be most helpful, they immediately looked to Florida. ASA Chairman Howard P. Milstein and the Milstein family have been active in the Florida business and philanthropic communities for many years making this expansion a natural choice.
“I am excited to announce the arrival of ASA to Sarasota, Florida. We are grateful for the very warm welcome we are receiving from our Florida supporters and look forward in continuing to make strides in our efforts with their help,” said Howard P. Milstein, Chairman of ASA.
Overseeing ASA’s Florida efforts will be ASA board member Eric Kaplan, Esq. and R. Dean Hautamaki, MD, FCCP, FACP, the organization’s newly named Senior Medical Advisor – Florida.
Mr. Kaplan is a Director of the Sarasota Private Trust Company and a trustee of the Louis and Gloria Flanzer Philanthropic Trust, the Sarasota Memorial Healthcare Foundation, and the Boys and Girls Clubs of Sarasota and DeSoto Counties. In addition, he is a board member of Forty Carrots of Sarasota and sits on the advisory council of Goodwill Industries of Manasota. Dr. Hautamaki is a board-certified physician practicing in Sarasota. He is Chief of Internal Medicine for Sarasota Memorial Hospital, Assistant Clinical Professor at Florida State College of Medicine, and Chair of the University of Florida College of Medicine Leadership Council. He is also on the board of Jewish Family & Children’s Service of the Suncoast based in Sarasota, the All Stars Children’s Foundation, and a trustee of the Louis and Gloria Flanzer Philanthropic Trust.
Over 34 years, ASA, who has received GuideStar’s Platinum Seal of Transparency, and its affiliates have sponsored more than $50 million in grants to support talented young scientists who have gone on to become top researchers in their fields. They work to find cutting-edge methods to prevent, detect and treat melanoma and other skin cancers and diseases. They have also made crucial investments in the well-being of future generations, putting great effort and resources into educating young people about skin health and sun safety.
ASA also recently announced its 2021 grant opportunities with over $400,000 in funding available in a variety of dermatologic focuses, including melanoma, psoriasis, atopic dermatitis, and vitiligo. Guidelines and applications can be found online at americanskin.org. The submission deadline is Wednesday, February 17, 2021 at 11:59 PM EST. Applications will be reviewed by ASA’s Medical Advisory Committee, which is comprised of experts in their respective fields.
ABOUT AMERICAN SKIN ASSOCIATION
ASA is a unique collaboration of patients, families, advocates, physicians, and scientists, and has evolved over thirty-four years into a leading force in efforts to defeat melanoma, skin cancer and important inflammatory and genetic skin diseases. Established to serve the now more than 100 million Americans – one third of the U.S. population – afflicted with skin disorders, the organization’s mission remains to: advance research, champion skin health – particularly among children, and drive public awareness about skin disease. For more information, visit americanskin.org.